Literature DB >> 29025560

Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise.

Carl J Lavie1, Ambarish Pandey2, Dennis H Lau3, Martin A Alpert4, Prashanthan Sanders3.   

Abstract

Both obesity and atrial fibrillation (AF) are increasing in epidemic proportions, and both increase the prevalence of cardiovascular disease events. Obesity has adverse effects on cardiovascular hemodynamics and cardiac structure and function, and increases the prevalence of AF, partly related to electroanatomic remodeling in obese patients. However, numerous studies, including in AF, have demonstrated an obesity paradox, where overweight and obese patients with these disorders have a better prognosis than do leaner patients with the same degree of severity of cardiovascular disease/AF. In this paper, the authors discuss special issues regarding AF in obesity, as well as the evidence that despite the presence of an obesity paradox, there are benefits of weight loss, physical activity/exercise training, and increases in cardiorespiratory fitness on the prognosis of obese patients with AF.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac arrhythmia; cardiovascular diseases; fat; fitness; heart rhythm

Mesh:

Year:  2017        PMID: 29025560     DOI: 10.1016/j.jacc.2017.09.002

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  70 in total

1.  Impact of low-voltage zones on the left atrial anterior wall on the reduction in the left atrial appendage flow velocity in persistent atrial fibrillation patients.

Authors:  Yuichi Hori; Shiro Nakahara; Naoki Nishiyama; Reiko Fukuda; Tomoaki Ukaji; Hirotsugu Sato; Yuri Koshikawa; Shu Inami; Tetsuya Ishikawa; Sayuki Kobayashi; Yoshihiko Sakai; Isao Taguchi
Journal:  J Interv Card Electrophysiol       Date:  2019-03-18       Impact factor: 1.900

Review 2.  [Lifestyle intervention in the primary prevention of cardiovascular diseases].

Authors:  Verena Heinicke; Martin Halle
Journal:  Herz       Date:  2020-02       Impact factor: 1.443

3.  Atrial remodeling and metabolic dysfunction in idiopathic isolated fibrotic atrial cardiomyopathy.

Authors:  Chang Cui; Xiaohong Jiang; Weizhu Ju; Jiaxian Wang; Daowu Wang; Zheng Sun; Minglong Chen
Journal:  Int J Cardiol       Date:  2018-04-26       Impact factor: 4.164

4.  Body mass index and all-cause mortality in patients with atrial fibrillation: insights from the China atrial fibrillation registry study.

Authors:  Lu Wang; Xin Du; Jian-Zeng Dong; Wen-Na Liu; Ying-Chun Zhou; Song-Nan Li; Xue-Yuan Guo; Chen-Xi Jiang; Rong-Hui Yu; Cai-Hua Sang; Ri-Bo Tang; De-Yong Long; Nian Liu; Rong Bai; Laurent Macle; Chang-Sheng Ma
Journal:  Clin Res Cardiol       Date:  2019-04-05       Impact factor: 5.460

5.  Predictors of non-pulmonary vein foci in paroxysmal atrial fibrillation.

Authors:  Keita Watanabe; Junichi Nitta; Osamu Inaba; Akira Sato; Yukihiro Inamura; Nobutaka Kato; Masahito Suzuki; Masahiko Goya; Kenzo Hirao; Tetsuo Sasano
Journal:  J Interv Card Electrophysiol       Date:  2020-05-28       Impact factor: 1.900

6.  Combined use of electro-anatomic mapping system and intracardiac echocardiography to achieve zero-fluoroscopy catheter ablation for treatment of paroxysmal atrial fibrillation: a single centre experience.

Authors:  Matevž Jan; David Žižek; Dimitrij Kuhelj; Nikola Lakič; Tine Prolič Kalinšek; Jernej Štublar; Luka Klemen; Andrej Pernat; Bor Antolič
Journal:  Int J Cardiovasc Imaging       Date:  2019-11-11       Impact factor: 2.357

7.  Body Composition in Patients with Atrial Fibrillation.

Authors:  Marzena Anaszewicz; Wioletta Banaś; Anna Wawrzeńczyk; Jacek Budzyński
Journal:  Acta Cardiol Sin       Date:  2019-09       Impact factor: 2.672

8.  Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.

Authors:  Carlo Fumagalli; Niccolò Maurizi; Sharlene M Day; Euan A Ashley; Michelle Michels; Steven D Colan; Daniel Jacoby; Niccolò Marchionni; Justin Vincent-Tompkins; Carolyn Y Ho; Iacopo Olivotto
Journal:  JAMA Cardiol       Date:  2020-01-01       Impact factor: 14.676

Review 9.  Sex differences in cardiometabolic disorders.

Authors:  Eva Gerdts; Vera Regitz-Zagrosek
Journal:  Nat Med       Date:  2019-11-07       Impact factor: 53.440

Review 10.  Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Authors:  Tiffany M Powell-Wiley; Paul Poirier; Lora E Burke; Jean-Pierre Després; Penny Gordon-Larsen; Carl J Lavie; Scott A Lear; Chiadi E Ndumele; Ian J Neeland; Prashanthan Sanders; Marie-Pierre St-Onge
Journal:  Circulation       Date:  2021-04-22       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.